CC Quote, Financials, Valuation and Earnings

Cleveland-Cliffs has a net margin of -1.8% compared to The Chemours's net margin of -5.3%. The Chemours's return on equity of 10.59% beat Cleveland-Cliffs's return on equity of -6.03%.

The Chemours has a consensus price target of $24.22, signalling upside risk potential of 36.69%. On the other hand Cleveland-Cliffs has an analysts' consensus of $14.40 which suggests that it could grow by 53.53%. Given that Cleveland-Cliffs has higher upside potential than The Chemours, analysts believe Cleveland-Cliffs is more attractive than The Chemours.

The Chemours has a beta of 1.798, which suggesting that the stock is 79.789% more volatile than S&P 500. In comparison Cleveland-Cliffs has a beta of 1.926, suggesting its more volatile than the S&P 500 by 92.634%.

The Chemours has a quarterly dividend of $0.25 per share corresponding to a yield of 5.64%. Cleveland-Cliffs offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Chemours pays -62.61% of its earnings as a dividend. Cleveland-Cliffs pays out -- of its earnings as a dividend.

The Chemours quarterly revenues are $1.5B, which are smaller than Cleveland-Cliffs quarterly revenues of $4.6B. The Chemours's net income of -$27M is higher than Cleveland-Cliffs's net income of -$242M. Notably, The Chemours's price-to-earnings ratio is 36.16x while Cleveland-Cliffs's PE ratio is 167.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours is 0.46x versus 0.23x for Cleveland-Cliffs. Usually stocks with elevated PS ratios are considered overvalued.

DuPont de Nemours has a net margin of -1.8% compared to The Chemours's net margin of 14.22%. The Chemours's return on equity of 10.59% beat DuPont de Nemours's return on equity of 3.28%.

The Chemours has a consensus price target of $24.22, signalling upside risk potential of 36.69%. On the other hand DuPont de Nemours has an analysts' consensus of $97.00 which suggests that it could grow by 25.52%. Given that The Chemours has higher upside potential than DuPont de Nemours, analysts believe The Chemours is more attractive than DuPont de Nemours.

The Chemours has a beta of 1.798, which suggesting that the stock is 79.789% more volatile than S&P 500. In comparison DuPont de Nemours has a beta of 1.338, suggesting its more volatile than the S&P 500 by 33.834%.

The Chemours has a quarterly dividend of $0.25 per share corresponding to a yield of 5.64%. DuPont de Nemours offers a yield of 1.97% to investors and pays a quarterly dividend of $0.38 per share. The Chemours pays -62.61% of its earnings as a dividend. DuPont de Nemours pays out 153.9% of its earnings as a dividend.

The Chemours quarterly revenues are $1.5B, which are smaller than DuPont de Nemours quarterly revenues of $3.2B. The Chemours's net income of -$27M is lower than DuPont de Nemours's net income of $454M. Notably, The Chemours's price-to-earnings ratio is 36.16x while DuPont de Nemours's PE ratio is 40.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours is 0.46x versus 2.69x for DuPont de Nemours. Usually stocks with elevated PS ratios are considered overvalued.

Koppers Holdings has a net margin of -1.8% compared to The Chemours's net margin of 4.11%. The Chemours's return on equity of 10.59% beat Koppers Holdings's return on equity of 14.89%.

The Chemours has a consensus price target of $24.22, signalling upside risk potential of 36.69%. On the other hand Koppers Holdings has an analysts' consensus of -- which suggests that it could grow by 108%. Given that Koppers Holdings has higher upside potential than The Chemours, analysts believe Koppers Holdings is more attractive than The Chemours.

The Chemours has a beta of 1.798, which suggesting that the stock is 79.789% more volatile than S&P 500. In comparison Koppers Holdings has a beta of 1.835, suggesting its more volatile than the S&P 500 by 83.476%.

The Chemours has a quarterly dividend of $0.25 per share corresponding to a yield of 5.64%. Koppers Holdings offers a yield of 0.9% to investors and pays a quarterly dividend of $0.07 per share. The Chemours pays -62.61% of its earnings as a dividend. Koppers Holdings pays out 5.61% of its earnings as a dividend. Koppers Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

The Chemours quarterly revenues are $1.5B, which are larger than Koppers Holdings quarterly revenues of $554.3M. The Chemours's net income of -$27M is lower than Koppers Holdings's net income of $22.8M. Notably, The Chemours's price-to-earnings ratio is 36.16x while Koppers Holdings's PE ratio is 8.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours is 0.46x versus 0.31x for Koppers Holdings. Usually stocks with elevated PS ratios are considered overvalued.

The Mosaic has a net margin of -1.8% compared to The Chemours's net margin of 4.35%. The Chemours's return on equity of 10.59% beat The Mosaic's return on equity of 3.06%.

The Chemours has a consensus price target of $24.22, signalling upside risk potential of 36.69%. On the other hand The Mosaic has an analysts' consensus of $32.77 which suggests that it could grow by 36.14%. Given that The Chemours has higher upside potential than The Mosaic, analysts believe The Chemours is more attractive than The Mosaic.

The Chemours has a beta of 1.798, which suggesting that the stock is 79.789% more volatile than S&P 500. In comparison The Mosaic has a beta of 1.343, suggesting its more volatile than the S&P 500 by 34.286%.

The Chemours has a quarterly dividend of $0.25 per share corresponding to a yield of 5.64%. The Mosaic offers a yield of 3.49% to investors and pays a quarterly dividend of $0.21 per share. The Chemours pays -62.61% of its earnings as a dividend. The Mosaic pays out 30.18% of its earnings as a dividend. The Mosaic's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

The Chemours quarterly revenues are $1.5B, which are smaller than The Mosaic quarterly revenues of $2.8B. The Chemours's net income of -$27M is lower than The Mosaic's net income of $122.2M. Notably, The Chemours's price-to-earnings ratio is 36.16x while The Mosaic's PE ratio is 21.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours is 0.46x versus 0.68x for The Mosaic. Usually stocks with elevated PS ratios are considered overvalued.